Apolipoprotein E: Risk factor for Alzheimer disease

M. S. Tsai, Eric George Tangalos, Ronald Carl Petersen, Glenn E. Smith, Daniel J Schaid, Emre Kokmen, Robert J. Ivnik, Stephen N Thibodeau

Research output: Contribution to journalArticle

234 Citations (Scopus)

Abstract

The apolipoprotein E gene (APOE) has three common alleles (ε2, ε3, and ε4) that determine six genotypes in the general population. In this study, we examined 77 patients with late-onset Alzheimer disease (AD), along with an equal number of age- and sex-matched controls, for an association with the APOE-ε4 allele. We show that the frequency of this allele among AD patients was significantly higher than that among the control population (.351 vs. .130, P = .000006). The genotype frequencies also differed between the two groups (P = .0002), with the APOE-ε4/ε3 genotype being the most common in the AD group and the APOE-ε3/ε3 being the most common in the control group. In the AD group, homozygosity for ε4 was found in nine individuals, whereas none was found in the control group. The odds ratio for AD, when associated with one or two ε4 alleles, was 4.6 (95% confidence interval [CI] 1.9- 12.3), while the odds ratio for AD, when associated with heterozygosity for APOE-ε4, was 3.6 (95% CI 1.5-9.8). Finally, the median age at onset among the AD patients decreased from 83 to 78 to 74 years as the number of APOE- ε4 alleles increased from 0 to 1 to 2, respectively (test for trend, P = .001). Our data, which are in agreement with recent reports, suggest that the APOE-ε4 allele is associated with AD and that this allelic variant may be an important risk factor for susceptibility to AD in the general population.

Original languageEnglish (US)
Pages (from-to)643-649
Number of pages7
JournalAmerican Journal of Human Genetics
Volume54
Issue number4
StatePublished - 1994

Fingerprint

Apolipoproteins E
Alzheimer Disease
Apolipoprotein E4
Alleles
Genes
Genotype
Odds Ratio
Apolipoprotein E3
Confidence Intervals
Population
Control Groups
Age of Onset
Gene Frequency

ASJC Scopus subject areas

  • Genetics

Cite this

Apolipoprotein E : Risk factor for Alzheimer disease. / Tsai, M. S.; Tangalos, Eric George; Petersen, Ronald Carl; Smith, Glenn E.; Schaid, Daniel J; Kokmen, Emre; Ivnik, Robert J.; Thibodeau, Stephen N.

In: American Journal of Human Genetics, Vol. 54, No. 4, 1994, p. 643-649.

Research output: Contribution to journalArticle

@article{582e6993d0074cf0855ca4cc8c0d2647,
title = "Apolipoprotein E: Risk factor for Alzheimer disease",
abstract = "The apolipoprotein E gene (APOE) has three common alleles (ε2, ε3, and ε4) that determine six genotypes in the general population. In this study, we examined 77 patients with late-onset Alzheimer disease (AD), along with an equal number of age- and sex-matched controls, for an association with the APOE-ε4 allele. We show that the frequency of this allele among AD patients was significantly higher than that among the control population (.351 vs. .130, P = .000006). The genotype frequencies also differed between the two groups (P = .0002), with the APOE-ε4/ε3 genotype being the most common in the AD group and the APOE-ε3/ε3 being the most common in the control group. In the AD group, homozygosity for ε4 was found in nine individuals, whereas none was found in the control group. The odds ratio for AD, when associated with one or two ε4 alleles, was 4.6 (95{\%} confidence interval [CI] 1.9- 12.3), while the odds ratio for AD, when associated with heterozygosity for APOE-ε4, was 3.6 (95{\%} CI 1.5-9.8). Finally, the median age at onset among the AD patients decreased from 83 to 78 to 74 years as the number of APOE- ε4 alleles increased from 0 to 1 to 2, respectively (test for trend, P = .001). Our data, which are in agreement with recent reports, suggest that the APOE-ε4 allele is associated with AD and that this allelic variant may be an important risk factor for susceptibility to AD in the general population.",
author = "Tsai, {M. S.} and Tangalos, {Eric George} and Petersen, {Ronald Carl} and Smith, {Glenn E.} and Schaid, {Daniel J} and Emre Kokmen and Ivnik, {Robert J.} and Thibodeau, {Stephen N}",
year = "1994",
language = "English (US)",
volume = "54",
pages = "643--649",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Apolipoprotein E

T2 - Risk factor for Alzheimer disease

AU - Tsai, M. S.

AU - Tangalos, Eric George

AU - Petersen, Ronald Carl

AU - Smith, Glenn E.

AU - Schaid, Daniel J

AU - Kokmen, Emre

AU - Ivnik, Robert J.

AU - Thibodeau, Stephen N

PY - 1994

Y1 - 1994

N2 - The apolipoprotein E gene (APOE) has three common alleles (ε2, ε3, and ε4) that determine six genotypes in the general population. In this study, we examined 77 patients with late-onset Alzheimer disease (AD), along with an equal number of age- and sex-matched controls, for an association with the APOE-ε4 allele. We show that the frequency of this allele among AD patients was significantly higher than that among the control population (.351 vs. .130, P = .000006). The genotype frequencies also differed between the two groups (P = .0002), with the APOE-ε4/ε3 genotype being the most common in the AD group and the APOE-ε3/ε3 being the most common in the control group. In the AD group, homozygosity for ε4 was found in nine individuals, whereas none was found in the control group. The odds ratio for AD, when associated with one or two ε4 alleles, was 4.6 (95% confidence interval [CI] 1.9- 12.3), while the odds ratio for AD, when associated with heterozygosity for APOE-ε4, was 3.6 (95% CI 1.5-9.8). Finally, the median age at onset among the AD patients decreased from 83 to 78 to 74 years as the number of APOE- ε4 alleles increased from 0 to 1 to 2, respectively (test for trend, P = .001). Our data, which are in agreement with recent reports, suggest that the APOE-ε4 allele is associated with AD and that this allelic variant may be an important risk factor for susceptibility to AD in the general population.

AB - The apolipoprotein E gene (APOE) has three common alleles (ε2, ε3, and ε4) that determine six genotypes in the general population. In this study, we examined 77 patients with late-onset Alzheimer disease (AD), along with an equal number of age- and sex-matched controls, for an association with the APOE-ε4 allele. We show that the frequency of this allele among AD patients was significantly higher than that among the control population (.351 vs. .130, P = .000006). The genotype frequencies also differed between the two groups (P = .0002), with the APOE-ε4/ε3 genotype being the most common in the AD group and the APOE-ε3/ε3 being the most common in the control group. In the AD group, homozygosity for ε4 was found in nine individuals, whereas none was found in the control group. The odds ratio for AD, when associated with one or two ε4 alleles, was 4.6 (95% confidence interval [CI] 1.9- 12.3), while the odds ratio for AD, when associated with heterozygosity for APOE-ε4, was 3.6 (95% CI 1.5-9.8). Finally, the median age at onset among the AD patients decreased from 83 to 78 to 74 years as the number of APOE- ε4 alleles increased from 0 to 1 to 2, respectively (test for trend, P = .001). Our data, which are in agreement with recent reports, suggest that the APOE-ε4 allele is associated with AD and that this allelic variant may be an important risk factor for susceptibility to AD in the general population.

UR - http://www.scopus.com/inward/record.url?scp=0028301820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028301820&partnerID=8YFLogxK

M3 - Article

C2 - 8128961

AN - SCOPUS:0028301820

VL - 54

SP - 643

EP - 649

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 4

ER -